Targeting of AML-leukemic stem cells with monoclonal antibodies

被引：1
|
作者：
Lee, Erwin M. [1 ]
Lock, Richard B. [1 ]
机构：
[1] Childrens Canc Inst Australia Med Res, Leukaemia Biol Program, Randwick, NSW 2031, Australia
来源：
FUTURE ONCOLOGY | 2009年 / 5卷 / 09期
关键词：
ACUTE MYELOID-LEUKEMIA; ACUTE MYELOGENOUS LEUKEMIA; EXPRESSION; HETEROGENEITY; CHEMOTHERAPY; ENGRAFTMENT; DIAGNOSIS; CD33; MICE;
D O I：
10.2217/FON.09.115
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1327 / 1330
页数：4
相关论文
共 50 条
  • [31] Monoclonal antibodies against human cancer stem cells
    Naujokat, Cord
    IMMUNOTHERAPY, 2014, 6 (03) : 291 - 308
  • [32] Targeting of mTOR in AML is associated with decreased growth of leukemic cells and downregulation of VEGF.
    Boehm, A
    Aichberger, KJ
    Mayerhofer, M
    Krauth, MT
    Derdak, S
    Pickl, WF
    Samorapoompichit, P
    Sillaber, C
    Florian, S
    Sonneck, K
    Sperr, WR
    Valent, P
    BLOOD, 2004, 104 (11) : 697A - 697A
  • [33] SELECTIVE INVITRO ERADICATION OF LEUKEMIC BLAST CELLS USING MONOCLONAL-ANTIBODIES
    MCANDREW, PF
    KOEFFLER, HP
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 284 - 284
  • [34] PHENOTYPE OF THE HAIRY-CELLS OF LEUKEMIC RETICULOENDOTHELIOSIS DEFINED BY MONOCLONAL-ANTIBODIES
    JANCKILA, AJ
    STELZER, GT
    WALLACE, JH
    YAM, LT
    JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1982, 32 (01): : 81 - 82
  • [35] PHENOTYPE OF THE HAIRY-CELLS OF LEUKEMIC RETICULOENDOTHELIOSIS DEFINED BY MONOCLONAL-ANTIBODIES
    JANCKILA, AJ
    STELZER, GT
    WALLACE, JH
    YAM, LT
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1983, 79 (04) : 431 - 437
  • [36] ANTIGENIC PHENOTYPE OF THE MYELOID LEUKEMIC-CELLS DEFINED BY MONOCLONAL-ANTIBODIES
    ROBAK, T
    KORYCKA, A
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 1987, 35 (01) : 33 - 42
  • [37] ULTRASTRUCTURAL CHARACTERIZATION OF LEUKEMIC-CELLS WITH THE IMMUNOGOLD METHOD AND MONOCLONAL-ANTIBODIES
    MATUTES, E
    CATOVSKY, D
    BRITISH JOURNAL OF CANCER, 1984, 50 (04) : 551 - 552
  • [38] Targeting Quiescent Leukemic Stem Cells and Overcoming Therapy Resistance in NUP98-NSD1 Fusion-Positive AML
    Wang, Ke
    Saniei, Shayan
    Poddar, Nikita
    Persaud, Subrina
    Sreenath, Meghana
    Quijada-alamo, Miguel
    Freed, Grace
    Mei, Anna Huo Chang
    Rahman, Noshin
    Chipuk, Jerry
    Wagenblast, Elvin
    BLOOD, 2024, 144 : 1340 - 1341
  • [39] Targeting leukemic stem cells in AML using the Bispecific CD33/CD3 BiTE® antibody AMG 330
    Krupka, C.
    Koehnke, T.
    Lichtenegger, F.
    Altmann, T.
    Vick, B.
    Konstandin, N.
    Metzeler, K.
    Jeremias, I
    Spiekermann, K.
    Riethmueller, G.
    Hiddemann, W.
    Subklewe, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 114 - 114
  • [40] Monoclonal antibodies targeting non-small cell lung cancer stem-like cells by multipotent cancer stem cell monoclonal antibody library
    Cao, Kaiyue
    Pan, Yunzhi
    Yu, Long
    Shu, Xiong
    Yang, Jing
    Sun, Linxin
    Sun, Lichao
    Yang, Zhihua
    Ran, Yuliang
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2017, 50 (02) : 587 - 596
12345